Lucie Blais
Chercheuse régulière
Hôpital du Sacré-Cœur-de-Montréal
Titulaire
Chaire pharmaceutique AstraZeneca en santé respiratoire
Professeure titulaire
Faculté de pharmacie, Université de Montréal
Lucie Blais est détentrice d’un doctorat en épidémiologie et biostatistique de l'Université McGill. Elle est professeure titulaire, vice-doyenne aux affaires professorales et secrétaire de faculté à la Faculté de pharmacie de l'Université de Montréal. Elle est chercheure au Centre de recherche de l'Hôpital du Sacré-Cœur de Montréal et chercheure associée au Centre de recherche du Centre hospitalier universitaire de Sherbrooke. Depuis 1999, Lucie Blais est co-titulaire de la Chaire de recherche Astra-Zeneca en santé respiratoire. Entre les années 2001 et 2012 elle a obtenu des bourses salariales du Fonds de Recherche du Québec – Santé (FRQS) et de l'Institut de recherche en santé du Canada (IRSC). Ses recherches portent essentiellement sur la pharmaco-épidémiologie des maladies respiratoires et sont majoritairement financées par les IRSC et le FRQS. Son programme de recherche comprend deux axes principaux, un premier sur la sécurité et l'efficacité des médicaments contre l'asthme pendant la grossesse, et le second, sur la prescription, l'utilisation, l’innocuité et l'efficacité en situation réelle des médicaments respiratoires. Elle compte à son actif plus de 150 publications scientifiques en plus de nombreuses supervisions d’étudiants aux cycles supérieurs.
Publications
8435569
Lucie Blais
1
chicago-author-date
10
date
desc
1
title
https://rechercheciusssnim.ca/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22Y3A23986%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Godbout-Parent%20et%20al.%22%2C%22parsedDate%22%3A%222024-03-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGodbout-Parent%2C%20Marim%26%23xE9%3Be%2C%20Nancy%20Julien%2C%20Hermine%20Lore%20Nguena%20Nguefack%2C%20M.%20Gabrielle%20Pag%26%23xE9%3B%2C%20Line%20Gu%26%23xE9%3Bnette%2C%20Lucie%20Blais%2C%20Sylvie%20Beaudoin%2C%20Christian%20Bertrand%2C%20and%20Ana%26%23xEF%3Bs%20Lacasse.%202024.%20%26%23x201C%3BChanging%20Society%2C%20Changing%20Research%3A%20Integrating%20Gender%20to%20Better%20Understand%20Physical%20and%20Psychological%20Treatments%20Use%20in%20Chronic%20Pain%20Management.%26%23x201D%3B%20%3Ci%3EPain%3C%5C%2Fi%3E%20165%20%283%29%3A%20674%26%23x2013%3B84.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2Fj.pain.0000000000003072%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2Fj.pain.0000000000003072%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Changing%20society%2C%20changing%20research%3A%20integrating%20gender%20to%20better%20understand%20physical%20and%20psychological%20treatments%20use%20in%20chronic%20pain%20management.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marim%5Cu00e9e%22%2C%22lastName%22%3A%22Godbout-Parent%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%22%2C%22lastName%22%3A%22Julien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hermine%20Lore%22%2C%22lastName%22%3A%22Nguena%20Nguefack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Gabrielle%22%2C%22lastName%22%3A%22Pag%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Line%22%2C%22lastName%22%3A%22Gu%5Cu00e9nette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvie%22%2C%22lastName%22%3A%22Beaudoin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Bertrand%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%5Cu00efs%22%2C%22lastName%22%3A%22Lacasse%22%7D%5D%2C%22abstractNote%22%3A%22Treatment%20of%20chronic%20pain%20should%20be%20multimodal%20and%20include%20pharmacological%2C%20physical%2C%20and%20psychological%20treatments.%20However%2C%20because%20various%20barriers%20to%20%20physical%20and%20psychological%20treatments%20%28PPTs%29%20exist%2C%20a%20better%20understanding%20of%20%20biopsychosocial%20factors%20leading%20to%20their%20use%20is%20relevant.%20This%20study%20aimed%20to%20%20explore%20the%20association%20between%20gender%20identity%2C%20gender-stereotyped%20personality%20%20traits%2C%20and%20the%20use%20of%20PPTs%20in%20chronic%20pain%20management.%20The%20ChrOnic%20Pain%20%20trEatment%20cohort%2C%20a%20self-reported%20data%20infrastructure%20resulting%20from%20a%20web-based%20%20recruitment%20of%201935%20people%20living%20with%20chronic%20pain%20%28Quebec%2C%20Canada%29%20was%20%20analyzed.%20Gender%20identity%20was%20operationalized%20as%20women%2C%20men%2C%20and%20nonbinary.%20%20Gender-stereotyped%20personality%20traits%20were%20measured%20using%20the%20Bem%20Sex-Role%20%20Inventory%20%28feminine%2C%20masculine%2C%20androgynous%2C%20undifferentiated%29.%20A%20checklist%20of%2031%20%20types%20of%20PPTs%20that%20can%20be%20used%20for%20chronic%20pain%20management%20was%20presented%20to%20%20participants%20%28yes%5C%2Fno%29.%20From%20the%201433%20participants%2C%2085.5%25%20reported%20using%20at%20least%20%20one%20PPT.%20Hot-cold%20therapies%20%2843.4%25%29%2C%20exercise%20%2841.9%25%29%2C%20and%20meditation%20%2835.2%25%29%20%20were%20the%20most%20frequently%20used%20PPTs%2C%20but%20most%20popular%20PPTs%20were%20not%20the%20same%20among%20%20women%20and%20men.%20Women%20reported%20a%20significantly%20higher%20use%20of%20PPTs%20in%20general%20%20%2887.2%25%20vs%2077.2%25%3B%20P%20%3C%200.001%29.%20Multivariable%20and%20interaction%20analyses%20showed%20that%20%20identifying%20as%20a%20man%20decreased%20the%20odds%20of%20reporting%20the%20use%20of%20PPTs%20%28odds%20ratio%3A%20%200.32%2C%2095%25%20confidence%20interval%3A%200.11-0.92%29%20but%20only%20among%20participants%20who%20scored%20%20high%20on%20both%20masculine%20and%20feminine%20personality%20traits%20%28those%20classified%20as%20%20androgynous%29.%20The%20high%20prevalence%20of%20PPTs%20use%20found%20in%20our%20study%20is%20positive.%20Our%20%20results%20are%20relevant%20for%20a%20more%20personalized%20promotion%20of%20PPTs%20for%20chronic%20pain%20%20management.%22%2C%22date%22%3A%222024%20Mar%201%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2Fj.pain.0000000000003072%22%2C%22ISSN%22%3A%221872-6623%200304-3959%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22EM25KHSB%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guertin%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuertin%2C%20Jason%20Robert%2C%20Naomi%20Hope%20Chouinard%2C%20Am%26%23xE9%3Blie%20Forget%2C%20and%20Lucie%20Blais.%202024.%20%26%23x201C%3BAdjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%26%23x201D%3B%20%3Ci%3EClinicoEconomics%20and%20Outcomes%20Research%26%23x202F%3B%3A%20CEOR%3C%5C%2Fi%3E%2016%3A675%26%23x2013%3B78.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FCEOR.S476426%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Adjusting%20Historical%20Costs%20for%20Inflation%20with%20the%20Use%20of%20Standardized%20Automated%20Tools.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20Robert%22%2C%22lastName%22%3A%22Guertin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%20Hope%22%2C%22lastName%22%3A%22Chouinard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Forget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2147%5C%2FCEOR.S476426%22%2C%22ISSN%22%3A%221178-6981%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22XTEW7HZJ%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zerriouh%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EZerriouh%2C%20Meriem%2C%20Gwenaelle%20De%20Clifford-Faug%26%23xE8%3Bre%2C%20Hermine%20Lore%20Nguena%20Nguefack%2C%20M.%20Gabrielle%20Pag%26%23xE9%3B%2C%20Line%20Gu%26%23xE9%3Bnette%2C%20Lucie%20Blais%2C%20and%20Ana%26%23xEF%3Bs%20Lacasse.%202024.%20%26%23x201C%3BPain%20Relief%20and%20Associated%20Factors%3A%20A%20Cross-Sectional%20Observational%20Web-Based%20Study%20in%20a%20Quebec%20Cohort%20of%20Persons%20Living%20with%20Chronic%20Pain.%26%23x201D%3B%20%3Ci%3EFrontiers%20in%20Pain%20Research%20%28Lausanne%2C%20Switzerland%29%3C%5C%2Fi%3E%205%3A1306479.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffpain.2024.1306479%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffpain.2024.1306479%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pain%20relief%20and%20associated%20factors%3A%20a%20cross-sectional%20observational%20web-based%20study%20in%20a%20Quebec%20cohort%20of%20persons%20living%20with%20chronic%20pain.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meriem%22%2C%22lastName%22%3A%22Zerriouh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwenaelle%22%2C%22lastName%22%3A%22De%20Clifford-Faug%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hermine%20Lore%22%2C%22lastName%22%3A%22Nguena%20Nguefack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Gabrielle%22%2C%22lastName%22%3A%22Pag%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Line%22%2C%22lastName%22%3A%22Gu%5Cu00e9nette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%5Cu00efs%22%2C%22lastName%22%3A%22Lacasse%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20Randomized%20clinical%20trials%20are%20used%20to%20evaluate%20the%20efficacy%20of%20various%20pain%20treatments%20individually%2C%20while%20a%20limited%20number%20of%20observational%20%20studies%20have%20portrayed%20the%20overall%20relief%20experienced%20by%20persons%20living%20with%20%20chronic%20pain.%20This%20study%20aimed%20to%20describe%20pain%20relief%20in%20real-world%20clinical%20%20settings%20and%20to%20identify%20associated%20factors.%20METHODS%3A%20This%20exploratory%20web-based%20%20cross-sectional%20study%20used%20data%20from%201%2C419%20persons%20recruited%20in%20the%20community.%20%20Overall%20pain%20relief%20brought%20by%20treatments%20used%20by%20participants%20was%20assessed%20using%20%20a%200%25-100%25%20scale%20%2810-unit%20increments%29.%20RESULTS%3A%20A%20total%20of%2018.2%25%20of%20participants%20%20reported%20minimal%20pain%20relief%20%280%25-20%25%29%2C%2060.0%25%20moderate%20to%20substantial%20pain%20relief%20%20%2830%25-60%25%29%2C%20and%2021.8%25%20extensive%20pain%20relief%20%2870%25-100%25%29.%20Multivariable%20multinomial%20%20regression%20analysis%20revealed%20factors%20significantly%20associated%20with%20greater%20pain%20%20relief%2C%20including%20reporting%20a%20stressful%20event%20as%20circumstances%20surrounding%20the%20%20onset%20of%20pain%2C%20living%20with%20pain%20for%20%5Cu226510%20years%2C%20milder%20pain%20intensity%2C%20less%20%20catastrophic%20thinking%2C%20use%20of%20prescribed%20pain%20medications%2C%20use%20of%20%20nonpharmacological%20pain%20treatments%2C%20access%20to%20a%20trusted%20healthcare%20professional%2C%20%20higher%20general%20health%20scores%2C%20and%20polypharmacy.%20Factors%20associated%20with%20lower%20%20pain%20relief%20included%20surgery%20as%20circumstances%20surrounding%20pain%20onset%2C%20use%20of%20%20over-the-counter%20pain%20medications%2C%20and%20severe%20psychological%20distress.%20DISCUSSION%3A%20%20In%20this%20community%20sample%20of%20persons%20living%20with%20chronic%20pain%2C%208%20out%20of%2010%20persons%20%20reported%20experiencing%20at%20least%20moderate%20relief%20with%20their%20treatment.%20The%20analysis%20%20has%20enabled%20us%20to%20explore%20potential%20modifiable%20factors%20as%20opportunities%20for%20%20improving%20the%20well-being%20of%20persons%20living%20with%20chronic%20pain.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffpain.2024.1306479%22%2C%22ISSN%22%3A%222673-561X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22356Q7WN3%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Audet%20et%20al.%22%2C%22parsedDate%22%3A%222024%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAudet%2C%20Claudie%2C%20Meriem%20Zerriouh%2C%20Hermine%20Lore%20Nguena%20Nguefack%2C%20Nancy%20Julien%2C%20M.%20Gabrielle%20Pag%26%23xE9%3B%2C%20Line%20Gu%26%23xE9%3Bnette%2C%20Lucie%20Blais%2C%20and%20Ana%26%23xEF%3Bs%20Lacasse.%202024.%20%26%23x201C%3BWhere%20We%20Live%20Matters%3A%20A%20Comparison%20of%20Chronic%20Pain%20Treatment%20between%20Remote%20and%20Non-Remote%20Regions%20of%20Quebec%2C%20Canada.%26%23x201D%3B%20%3Ci%3EFrontiers%20in%20Pain%20Research%20%28Lausanne%2C%20Switzerland%29%3C%5C%2Fi%3E%205%3A1291101.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffpain.2024.1291101%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffpain.2024.1291101%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Where%20we%20live%20matters%3A%20a%20comparison%20of%20chronic%20pain%20treatment%20between%20remote%20and%20non-remote%20regions%20of%20Quebec%2C%20Canada.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudie%22%2C%22lastName%22%3A%22Audet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meriem%22%2C%22lastName%22%3A%22Zerriouh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hermine%20Lore%22%2C%22lastName%22%3A%22Nguena%20Nguefack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nancy%22%2C%22lastName%22%3A%22Julien%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Gabrielle%22%2C%22lastName%22%3A%22Pag%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Line%22%2C%22lastName%22%3A%22Gu%5Cu00e9nette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%5Cu00efs%22%2C%22lastName%22%3A%22Lacasse%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Where%20a%20person%20lives%20is%20a%20recognized%20socioeconomic%20determinant%20of%20health%20and%20influences%20healthcare%20access.%20This%20study%20aimed%20to%20compare%20the%20pain%20%20treatment%20profile%20of%20persons%20with%20chronic%20pain%20%28CP%29%20living%20in%20remote%20regions%20to%20%20those%20living%20in%20non-remote%20regions%20%28near%20or%20in%20major%20urban%20centers%29.%20METHODS%3A%20A%20%20cross-sectional%20study%20was%20performed%20among%20persons%20living%20with%20CP%20across%20Quebec.%20%20In%20a%20web-based%20questionnaire%2C%20participants%20were%20asked%20to%20report%20in%20which%20of%20the%20%2017%20administrative%20regions%20they%20were%20living%20%28six%20considered%20%5C%22remote%5C%22%29.%20Pain%20%20treatment%20profile%20was%20drawn%20up%20using%20seven%20variables%3A%20use%20of%20prescribed%20pain%20%20medications%2C%20over-the-counter%20pain%20medications%2C%20non-pharmacological%20pain%20%20treatments%2C%20multimodal%20approach%2C%20access%20to%20a%20trusted%20healthcare%20professional%20for%20%20pain%20management%2C%20excessive%20polypharmacy%20%28%5Cu226510%20medications%29%2C%20and%20use%20of%20cannabis%20%20for%20pain.%20RESULTS%3A%201%2C399%20participants%20completed%20the%20questionnaire%20%28women%3A%2083.4%25%2C%20%20mean%20age%3A%2050%20years%2C%20living%20in%20remote%20regions%3A%2023.8%25%29.%20As%20compared%20to%20persons%20%20living%20in%20remote%20regions%2C%20those%20living%20in%20non-remote%20regions%20were%20more%20likely%20to%20%20report%20using%20prescribed%20pain%20medications%20%2883.8%25%20vs.%2067.4%25%29%2C%20a%20multimodal%20approach%20%20%2881.5%25%20vs.%2075.5%25%29%2C%20experience%20excessive%20polypharmacy%20%2828.1%25%20vs.%2019.1%25%29%2C%20and%20%20report%20using%20cannabis%20for%20pain%20%2833.1%25%20vs.%2020.7%25%29%20%28bivariable%20p%5Cu2009%3C%5Cu20090.05%29.%20Only%20the%20%20use%20of%20prescribed%20medications%20as%20well%20as%20cannabis%20remained%20significantly%20%20associated%20with%20the%20region%20of%20residence%20in%20the%20multivariable%20models.%20DISCUSSION%3A%20%20There%20are%20differences%20in%20treatment%20profiles%20of%20persons%20with%20CP%20depending%20on%20the%20%20region%20they%20live.%20Our%20results%20highlight%20the%20importance%20of%20considering%20remoteness%2C%20%20and%20not%20only%20rurality%2C%20when%20it%20comes%20to%20better%20understanding%20the%20determinants%20of%20%20pain%20management.%22%2C%22date%22%3A%222024%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3389%5C%2Ffpain.2024.1291101%22%2C%22ISSN%22%3A%222673-561X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22ZHXLW53N%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22De%20Clifford-Faug%5Cu00e8re%20et%20al.%22%2C%22parsedDate%22%3A%222023-08-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDe%20Clifford-Faug%26%23xE8%3Bre%2C%20Gwena%26%23xEB%3Blle%2C%20Hermine%20Lore%20Nguena%20Nguefack%2C%20Manon%20Choini%26%23xE8%3Bre%2C%20M.%20Gabrielle%20Pag%26%23xE9%3B%2C%20Lucie%20Blais%2C%20Line%20Gu%26%23xE9%3Bnette%2C%20Marc%20Dorais%2C%20and%20Ana%26%23xEF%3Bs%20Lacasse.%202023.%20%26%23x201C%3BTrends%20in%20Prescription%20Chronic%20Pain%20Medication%20Use%20before%20and%20during%20the%20First%20Wave%20of%20the%20COVID-19%20Pandemic%20in%20Qu%26%23xE9%3Bbec%2C%20Canada%3A%20An%20Interrupted%20Time%20Series%26%23xA0%3B%20Analysis.%26%23x201D%3B%20%3Ci%3EInternational%20Journal%20of%20Environmental%20Research%20and%20Public%20Health%3C%5C%2Fi%3E%2020%20%2815%29.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijerph20156493%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fijerph20156493%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Trends%20in%20Prescription%20Chronic%20Pain%20Medication%20Use%20before%20and%20during%20the%20First%20Wave%20of%20the%20COVID-19%20Pandemic%20in%20Qu%5Cu00e9bec%2C%20Canada%3A%20An%20Interrupted%20Time%20Series%20%20Analysis.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwena%5Cu00eblle%22%2C%22lastName%22%3A%22De%20Clifford-Faug%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hermine%20Lore%22%2C%22lastName%22%3A%22Nguena%20Nguefack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manon%22%2C%22lastName%22%3A%22Choini%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Gabrielle%22%2C%22lastName%22%3A%22Pag%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Line%22%2C%22lastName%22%3A%22Gu%5Cu00e9nette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Dorais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%5Cu00efs%22%2C%22lastName%22%3A%22Lacasse%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20In%20Canada%2C%20a%20state%20of%20health%20emergency%20was%20declared%20in%20May%202020%20as%20a%20result%20of%20the%20COVID-19%20pandemic.%20This%20study%20aimed%20to%20assess%20trends%20in%20the%20use%20of%20%20prescription%20medication%20for%20pain%20management%20by%20people%20living%20with%20chronic%20pain%20%20before%20and%20during%20the%20first%20wave%20of%20the%20pandemic.%20METHODS%3A%20Participants%20%28n%20%3D%20177%29%20%20were%20adults%20reporting%20chronic%20pain%20who%20had%20completed%20a%20web-based%20questionnaire%20in%20%202019%20and%20for%20whom%20complete%20longitudinal%20private%20and%20public%20insurance%20prescription%20%20claims%20were%20available.%20The%20monthly%20prevalence%20of%20medication%20use%20for%20nonsteroidal%20%20anti-inflammatory%20drugs%20%28NSAIDs%29%2C%20opioids%2C%20and%20prescribed%20cannabinoids%20was%20%20assessed.%20An%20interrupted%20time%20series%20analysis%20was%20then%20performed%20to%20evaluate%20if%20%20the%20COVID-19%20pandemic%20had%20had%20an%20impact%20on%20trends%20in%20pain%20medication%20use.%20%20RESULTS%3A%20The%20beginning%20of%20the%20first%20wave%20of%20the%20pandemic%20was%20associated%20with%20the%20%20onset%20of%20a%20downward%20trend%20in%20opioid%20use%20%28p%20%3C%200.05%29%3B%20no%20such%20association%20was%20found%20%20regarding%20NSAIDs.%20However%2C%20point%20prevalence%20of%20opioid%20use%20at%20the%20beginning%20%28Nov.%20%202019%29%20and%20at%20the%20end%20%28Mai%202020%29%20of%20the%20study%20period%20remained%20somewhat%20stable%20%20%2817.0%25%20vs.%2016.4%25%29.%20Regarding%20prescribed%20cannabinoids%2C%20a%20gradual%20increase%20in%20use%20%20was%20observed%20over%20the%20entire%20study%20period%20independently%20from%20the%20impact%20of%20the%20%20first%20wave%20of%20the%20pandemic%20%2815.3%25%20vs.%2022.6%25%2C%20p%20%3C%200.05%29.%20CONCLUSION%3A%20While%20the%20%20occurrence%20of%20the%20first%20wave%20did%20have%20an%20impact%20on%20opioid%20use%20among%20people%20living%20%20with%20chronic%20pain%2C%20access%20to%20and%20use%20of%20opioids%20appear%20to%20have%20returned%20to%20normal%20%20before%20the%20end%20of%20the%20first%20wave%20of%20COVID-19.%22%2C%22date%22%3A%222023%20Aug%201%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3390%5C%2Fijerph20156493%22%2C%22ISSN%22%3A%221660-4601%201661-7827%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%224NNYHPAE%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gu%5Cu00e9nette%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGu%26%23xE9%3Bnette%2C%20Line%2C%20V%26%23xE9%3Bronique%20Turcotte%2C%20Laurianne%20B%26%23xE9%3Blanger%2C%20Lucie%20Blais%2C%20Caroline%20Sirois%2C%20Carlotta%20Lunghi%2C%20and%20Polly%20Duncan.%202023.%20%26%23x201C%3BMultimorbidity%20Treatment%20Burden%20Questionnaire%20%28MTBQ%29%3A%20Translation%2C%20Cultural%20Adaptation%2C%20and%20Validation%20in%20French-Canadian.%26%23x201D%3B%20%3Ci%3ECanadian%20Journal%20on%20Aging%20%3D%20La%20Revue%20Canadienne%20Du%20Vieillissement%3C%5C%2Fi%3E%2042%20%281%29%3A%20126%26%23x2013%3B34.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1017%5C%2FS0714980822000058%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1017%5C%2FS0714980822000058%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multimorbidity%20Treatment%20Burden%20Questionnaire%20%28MTBQ%29%3A%20Translation%2C%20Cultural%20Adaptation%2C%20and%20Validation%20in%20French-Canadian.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Line%22%2C%22lastName%22%3A%22Gu%5Cu00e9nette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%5Cu00e9ronique%22%2C%22lastName%22%3A%22Turcotte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurianne%22%2C%22lastName%22%3A%22B%5Cu00e9langer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Caroline%22%2C%22lastName%22%3A%22Sirois%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carlotta%22%2C%22lastName%22%3A%22Lunghi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Polly%22%2C%22lastName%22%3A%22Duncan%22%7D%5D%2C%22abstractNote%22%3A%22Reliable%20treatment%20burden%20measures%20are%20needed%20given%20the%20aging%20population%20and%20the%20associated%20increase%20in%20multimorbidity%20and%20polypharmacy.%20Treatment%20burden%20is%20%20defined%20as%20the%20effort%20to%20care%20for%20one%27s%20health%20and%20the%20resulting%20impact%20on%20one%27s%20%20daily%20life.%20This%20study%20aimed%20to%20translate%20the%20Multimorbidity%20Treatment%20Burden%20%20Questionnaire%20%28MTBQ%29%20for%20French-Canadians%20and%20assess%20its%20reliability%20and%20%20validity.%20The%20MTBQ%20was%20translated%20and%20tested%20with%20cognitive%20debriefing%20%20interviews%2C%20and%20the%20French%20version%20%28MTBQ-F%29%20was%20then%20administered%202%20times%20among%20%20105%20participants.%20Reliability%20and%20validity%20were%20examined%20using%20the%20intra-class%20%20correlation%20coefficient%20%28ICC%29%2C%20Cronbach%27s%20alpha%2C%20and%20Spearman%27s%20correlations.%20The%20%20median%20global%20MTBQ-F%20scores%20were%2032.69%20%28interquartile%20range%20%5BIQR%5D%3A%2021.15-48.08%29%20%20and%2030.77%20%28IQR%3A%2021.15-46.15%29%20for%20the%20first%20and%20second%20administrations%2C%20%20respectively.%20Test-retest%20%28ICC%3A%200.73%3B%2095%25%20CI%3A%200.63-0.81%29%20and%20internal%20consistency%20%20reliability%20%28Cronbach%27s%20alpha%3A%200.80%29%20were%20good.%20There%20was%20a%20moderate%20positive%20%20correlation%20between%20the%20MTBQ-F%20score%20and%20the%20number%20of%20self-reported%20conditions%20%20%28rho%3A%200.28%29.%20This%20valid%20instrument%20could%20identify%20patients%20experiencing%20a%20high%20%20treatment%20burden%20and%20assess%20the%20impact%20of%20interventions%20among%20them.%22%2C%22date%22%3A%222023%20Mar%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1017%5C%2FS0714980822000058%22%2C%22ISSN%22%3A%221710-1107%200714-9808%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22XH58WKDV%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zahlan%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EZahlan%2C%20Ghita%2C%20Gwenaelle%20De%20Clifford-Faug%26%23xE8%3Bre%2C%20Hermine%20Lore%20Nguena%20Nguefack%2C%20Line%20Gu%26%23xE9%3Bnette%2C%20M.%20Gabrielle%20Pag%26%23xE9%3B%2C%20Lucie%20Blais%2C%20and%20Ana%26%23xEF%3Bs%20Lacasse.%202023.%20%26%23x201C%3BPolypharmacy%20and%20Excessive%20Polypharmacy%20Among%20Persons%20Living%20with%20Chronic%20Pain%3A%20A%20Cross-Sectional%20Study%20on%20the%20Prevalence%20and%20Associated%20Factors.%26%23x201D%3B%20%3Ci%3EJournal%20of%20Pain%20Research%3C%5C%2Fi%3E%2016%3A3085%26%23x2013%3B3100.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FJPR.S411451%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2147%5C%2FJPR.S411451%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Polypharmacy%20and%20Excessive%20Polypharmacy%20Among%20Persons%20Living%20with%20Chronic%20Pain%3A%20A%20Cross-Sectional%20Study%20on%20the%20Prevalence%20and%20Associated%20Factors.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ghita%22%2C%22lastName%22%3A%22Zahlan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwenaelle%22%2C%22lastName%22%3A%22De%20Clifford-Faug%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hermine%20Lore%22%2C%22lastName%22%3A%22Nguena%20Nguefack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Line%22%2C%22lastName%22%3A%22Gu%5Cu00e9nette%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20Gabrielle%22%2C%22lastName%22%3A%22Pag%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ana%5Cu00efs%22%2C%22lastName%22%3A%22Lacasse%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%3A%20Polypharmacy%20can%20be%20defined%20as%20the%20concomitant%20use%20of%20%5Cu22655%20medications%20and%20excessive%20polypharmacy%2C%20as%20the%20use%20of%20%5Cu226510%20medications.%20Objectives%20were%20to%20%281%29%20%20assess%20the%20prevalence%20of%20polypharmacy%20and%20excessive%20polypharmacy%20among%20persons%20%20living%20with%20chronic%20pain%2C%20and%20%282%29%20identify%20sociodemographic%20and%20clinical%20factors%20%20associated%20with%20excessive%20polypharmacy.%20PATIENTS%20AND%20METHODS%3A%20This%20%20cross-sectional%20study%20used%20data%20from%201342%20persons%20from%20the%20ChrOnic%20Pain%20trEatment%20%20%28COPE%29%20Cohort%20%28Quebec%2C%20Canada%29.%20The%20self-reported%20number%20of%20medications%20currently%20%20used%20by%20participants%20%28regardless%20of%20whether%20they%20were%20prescribed%20or%20taken%20%20over-the-counter%2C%20or%20were%20used%20for%20treating%20pain%20or%20other%20health%20issues%29%20was%20%20categorized%20to%20assess%20polypharmacy%20and%20excessive%20polypharmacy.%20RESULTS%3A%20%20Participants%20reported%20using%20an%20average%20of%206%20medications%20%28median%3A%205%29.%20The%20%20prevalence%20of%20polypharmacy%20was%2071.4%25%20%2895%25%20CI%3A%2069.0-73.8%29%20and%20excessive%20%20polypharmacy%20was%2025.9%25%20%2895%25%20CI%3A%2023.6-28.3%29.%20No%20significant%20differences%20were%20found%20%20across%20gender%20identity%20groups.%20Multivariable%20logistic%20regression%20revealed%20that%20%20factors%20associated%20with%20greater%20chances%20of%20reporting%20excessive%20polypharmacy%20%28vs%20%20%3C10%20medications%29%20included%20being%20born%20in%20Canada%2C%20using%20prescribed%20pain%20%20medications%2C%20and%20reporting%20greater%20pain%20intensity%20%280-10%29%20or%20pain%20relief%20from%20%20currently%20used%20pain%20treatments%20%280-100%25%29.%20Factors%20associated%20with%20lower%20chances%20of%20%20excessive%20polypharmacy%20were%20using%20physical%20and%20psychological%20pain%20treatments%2C%20%20reporting%20better%20general%20health%5C%2Fphysical%20functioning%2C%20considering%20pain%20to%20be%20%20terrible%5C%2Ffeeling%20like%20it%20will%20never%20get%20better%2C%20and%20being%20employed.%20CONCLUSION%3A%20%20Polypharmacy%20is%20the%20rule%20rather%20than%20the%20exception%20among%20persons%20living%20with%20%20chronic%20pain.%20Close%20monitoring%20and%20evaluation%20of%20the%20different%20medications%20used%20%20are%20important%20for%20all%20persons%2C%20especially%20those%20with%20limited%20access%20to%20care.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2147%5C%2FJPR.S411451%22%2C%22ISSN%22%3A%221178-7090%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22V5QFKDCR%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Yousif%20et%20al.%22%2C%22parsedDate%22%3A%222022-12%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EYousif%2C%20Alia%2C%20Catherine%20Lemi%26%23xE8%3Bre%2C%20Am%26%23xE9%3Blie%20Forget%2C%20Marie-France%20Beauchesne%2C%20and%20Lucie%20Blais.%202022.%20%26%23x201C%3BFeasibility%20of%20Implementing%20a%20Web-Based%20Tool%20Built%20from%20Pharmacy%20Claims%20Data%20%28e-MEDRESP%29%20to%20Monitor%20Adherence%20to%20Respiratory%20Medications%20in%20Primary%20Care.%26%23x201D%3B%20%3Ci%3ECurrent%20Medical%20Research%20and%20Opinion%3C%5C%2Fi%3E%2038%20%2812%29%3A%202055%26%23x2013%3B67.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F03007995.2022.2135835%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F03007995.2022.2135835%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Feasibility%20of%20implementing%20a%20web-based%20tool%20built%20from%20pharmacy%20claims%20data%20%28e-MEDRESP%29%20to%20monitor%20adherence%20to%20respiratory%20medications%20in%20primary%20care.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alia%22%2C%22lastName%22%3A%22Yousif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Lemi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Am%5Cu00e9lie%22%2C%22lastName%22%3A%22Forget%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-France%22%2C%22lastName%22%3A%22Beauchesne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20e-MEDRESP%20is%20a%20novel%20web-based%20tool%20that%20provides%20easily%20interpretable%20information%20on%20patient%20adherence%20to%20asthma%5C%2Fchronic%20obstructive%20pulmonary%20disease%20%20%28COPD%29%20medications%2C%20using%20pharmacy%20claims%20data.%20This%20study%20investigated%20the%20%20feasibility%20of%20implementing%20e-MEDRESP%20in%20primary%20care.%20MATERIAL%20AND%20METHODS%3A%20In%20%20this%2016-month%20prospective%20cohort%20study%2C%20e-MEDRESP%20was%20integrated%20into%20electronic%20%20medical%20records.%20Nineteen%20family%20physicians%20and%20346%20of%20their%20patients%20were%20%20enrolled.%20Counters%20embedded%20in%20the%20tool%20tracked%20physician%20use%20during%20the%20%20follow-up.%20Patient%5C%2Fphysician%20satisfaction%20with%20e-MEDRESP%20was%20evaluated%20though%20%20telephone%20interviews%20and%20online%20questionnaires.%20The%20capacity%20of%20e-MEDRESP%20to%20%20improve%20adherence%20was%20explored%20using%20a%20pre-post%20analysis.%20RESULTS%3A%20Overall%2C%20245%20%20patients%20had%20at%20least%20one%20medical%20visit%20during%20follow-up.%20e-MEDRESP%20was%20consulted%20%20by%2015%20%2879%25%29%20physicians%20for%2085%20%2835%25%29%20patients%20during%20clinic%20visits.%20Seventy-three%20%20patients%20participated%20in%20telephone%20interviews%3B%2084%25%20reported%20discussing%20their%20%20medication%20use%20with%20their%20physician%3B%2033%25%20viewed%20their%20e-MEDRESP%20report%20and%20%20indicated%20that%20it%20was%20easy%20to%20interpret.%20The%20physicians%20reported%20that%20the%20tool%20%20facilitated%20their%20evaluation%20of%20their%20patients%27%20medication%20adherence%20%20%28mean%5Cu2009%5Cu00b1%5Cu2009standard%20deviation%20rating%3A%204.8%5Cu2009%5Cu00b1%5Cu20090.7%2C%20on%20a%205-point%20Likert%20scale%29.%20%20Although%20the%20pre-post%20analysis%20did%20not%20reveal%20improved%20adherence%20in%20the%20overall%20%20cohort%2C%20adherence%20improved%20significantly%20in%20patients%20whose%20adherence%20level%20was%20%20%3C80%25%20and%20who%20were%20prescribed%20inhaled%20corticosteroids%20%2826.9%25%20%5B95%25%20CI%2014.3-39.3%25%5D%29%20%20or%20long-acting%20muscarinic%20agents%20%2826.4%25%20%5B95%25%20CI%2012.4-40.2%25%5D%29.%20CONCLUSIONS%3A%20%20e-MEDRESP%20was%20successfully%20integrated%20in%20clinical%20practice.%20It%20could%20serve%20as%20a%20%20useful%20tool%20to%20help%20physicians%20monitor%20their%20patients%27%20medication%20adherence.%22%2C%22date%22%3A%222022%20Dec%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1080%5C%2F03007995.2022.2135835%22%2C%22ISSN%22%3A%221473-4877%200300-7995%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%222MYXVHI2%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bahamyirou%20et%20al.%22%2C%22parsedDate%22%3A%222022-11-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBahamyirou%2C%20Asma%2C%20Mireille%20E.%20Schnitzer%2C%20Edward%20H.%20Kennedy%2C%20Lucie%20Blais%2C%20and%20Yi%20Yang.%202022.%20%26%23x201C%3BDoubly%20Robust%20Adaptive%20LASSO%20for%20Effect%20Modifier%20Discovery.%26%23x201D%3B%20%3Ci%3EThe%20International%20Journal%20of%20Biostatistics%3C%5C%2Fi%3E%2018%20%282%29%3A%20307%26%23x2013%3B27.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1515%5C%2Fijb-2020-0073%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1515%5C%2Fijb-2020-0073%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Doubly%20robust%20adaptive%20LASSO%20for%20effect%20modifier%20discovery.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Asma%22%2C%22lastName%22%3A%22Bahamyirou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mireille%20E.%22%2C%22lastName%22%3A%22Schnitzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20H.%22%2C%22lastName%22%3A%22Kennedy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yi%22%2C%22lastName%22%3A%22Yang%22%7D%5D%2C%22abstractNote%22%3A%22Effect%20modification%20occurs%20when%20the%20effect%20of%20a%20treatment%20on%20an%20outcome%20differsaccording%20to%20the%20level%20of%20some%20pre-treatment%20variable%20%28the%20effect%20%20modifier%29.%20Assessing%20an%20effect%20modifier%20is%20not%20a%20straight-forward%20task%20even%20for%20a%20%20subject%20matter%20expert.%20In%20this%20paper%2C%20we%20propose%20a%20two-stageprocedure%20to%20%20automatically%20selecteffect%20modifying%20variables%20in%20a%20Marginal%20Structural%20Model%20%20%28MSM%29%20with%20a%20single%20time%20point%20exposure%20based%20on%20the%20two%20nuisance%20quantities%20%28the%20%20conditionaloutcome%20expectation%20and%20propensity%20score%29.%20We%20highlight%20the%20%20performance%20of%20our%20proposal%20in%20a%20simulation%20study.%20Finally%2C%20to%20illustrate%20%20tractability%20of%20our%20proposed%20methods%2C%20we%20apply%20them%20to%20analyze%20a%20set%20of%20pregnancy%20%20data.%20We%20estimate%20the%20conditional%20expected%20difference%20in%20the%20counterfactual%20birth%20%20weight%20if%20all%20women%20were%20exposed%20to%20inhaled%20corticosteroids%20during%20pregnancy%20%20versus%20the%20counterfactual%20birthweight%20if%20all%20women%20were%20not%2C%20using%20data%20from%20%20asthma%20medications%20during%20pregnancy.%22%2C%22date%22%3A%222022%20Nov%201%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1515%5C%2Fijb-2020-0073%22%2C%22ISSN%22%3A%221557-4679%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%2C%7B%22key%22%3A%22UEKQNS3V%22%2C%22library%22%3A%7B%22id%22%3A8435569%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Turcotte%20et%20al.%22%2C%22parsedDate%22%3A%222022-09%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ETurcotte%2C%20Claudie%2C%20R%26%23xE9%3Bbecca%20F%26%23xE9%3Bn%26%23xE9%3Blon-Dimanche%2C%20Catherine%20Lemi%26%23xE8%3Bre%2C%20Marie-France%20Beauchesne%2C%20Bachir%20Abou-Atm%26%23xE9%3B%2C%20Isabelle%20Chabot%2C%20and%20Lucie%20Blais.%202022.%20%26%23x201C%3BDevelopment%20of%20a%20Community%20Pharmacy-Based%20Intervention%20for%20Patients%20with%20Uncontrolled%20Asthma.%26%23x201D%3B%20%3Ci%3EExploratory%20Research%20in%20Clinical%20and%20Social%20Pharmacy%3C%5C%2Fi%3E%207%20%28September%29%3A100167.%20%3Ca%20class%3D%27zp-DOIURL%27%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rcsop.2022.100167%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rcsop.2022.100167%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Development%20of%20a%20community%20pharmacy-based%20intervention%20for%20patients%20with%20uncontrolled%20asthma.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudie%22%2C%22lastName%22%3A%22Turcotte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%5Cu00e9becca%22%2C%22lastName%22%3A%22F%5Cu00e9n%5Cu00e9lon-Dimanche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Lemi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-France%22%2C%22lastName%22%3A%22Beauchesne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bachir%22%2C%22lastName%22%3A%22Abou-Atm%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabelle%22%2C%22lastName%22%3A%22Chabot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucie%22%2C%22lastName%22%3A%22Blais%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Achieving%20asthma%20control%20is%20often%20difficult%2C%20despite%20the%20availability%20of%20effective%20medications.%20Because%20of%20their%20expertise%2C%20regular%20contact%20with%20%20patients%2C%20and%20accessibility%2C%20community%20pharmacists%20can%20play%20an%20important%20role%20in%20%20helping%20patients%20manage%20uncontrolled%20asthma.%20OBJECTIVE%3A%20To%20develop%20a%20community%20%20pharmacy-based%20intervention%20for%20improving%20asthma%20control%20in%20patients%20with%20%20uncontrolled%20moderate%20to%20severe%20asthma.%20METHODS%3A%20A%20qualitative%20study%20involving%20%20two%20focus%20groups%20with%20six%20and%20five%20community%20pharmacists%2C%20respectively%2C%20five%20%20individual%20interviews%20with%20community%20pharmacists%2C%20and%20three%20individual%20interviews%20%20with%20asthma%20patients%20was%20conducted%20using%20semi-structured%20interview%20guides.%20Focus%20%20groups%20aimed%20to%20develop%20the%20first%20prototype%20of%20the%20intervention%20and%20the%20topics%20%20included%20criteria%20to%20identify%20patients%20with%20uncontrolled%20asthma%2C%20content%20of%20the%20%20intervention%20to%20manage%20uncontrolled%20asthma%2C%20and%20potential%20logistical%20issues.%20%20Interviews%20were%20subsequently%20conducted%20with%20individual%20pharmacists%20and%20asthma%20%20patients%20to%20evaluate%20the%20prototype%20and%20finalize%20the%20intervention.%20The%20interviews%20%20and%20focus%20group%20transcripts%20were%20analyzed%20thematically%2C%20using%20an%20iterative%20%20process.%20RESULTS%3A%20In%20focus%20groups%20and%20interviews%2C%20the%20pharmacists%20discussed%20how%20%20they%20screen%20patients%20with%20uncontrolled%20asthma%20using%20prescriptions%20refills%2C%20their%20%20needs%20for%20a%20convenient%20tool%20to%20assess%20asthma%20control%2C%20the%20necessity%20to%20identify%20%20causes%20of%20uncontrolled%20asthma%20to%20guide%20asthma%20management%20strategies%2C%20and%20the%20%20importance%20of%20patient%20follow-up.%20During%20interviews%2C%20patients%20shared%20their%20%20interest%20for%20the%20commitment%20of%20pharmacists%20to%20managing%20asthma.%20The%20final%20%20intervention%20consists%20of%20structured%20face-to-face%20counselling%20sessions%20at%20%20community%20pharmacies%2C%20with%20six%20steps%3A%20screening%20of%20patients%20with%20potential%20%20uncontrolled%20moderate%20to%20severe%20asthma%2C%20assessment%20of%20asthma%20control%2C%20%20identification%20of%20the%20causes%20of%20uncontrolled%20asthma%2C%20strategies%20for%20controlling%20%20asthma%2C%20an%20optional%20follow-up%20at%20the%20next%20prescription%20refill%2C%20and%20a%20follow-up%203%20%20months%20after%20the%20initial%20intervention.%20CONCLUSIONS%3A%20The%20patients%20and%20community%20%20pharmacists%20reached%20consensus%20on%20the%20intervention%27s%20key%20elements%20and%20provided%20%20support%20for%20implementing%20the%20intervention%20in%20community%20pharmacies.%22%2C%22date%22%3A%222022%20Sep%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rcsop.2022.100167%22%2C%22ISSN%22%3A%222667-2766%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22I2NNHTR6%22%2C%22KNCYYV6T%22%5D%2C%22dateModified%22%3A%222025-01-22T15%3A43%3A34Z%22%7D%7D%5D%7D
Godbout-Parent, Marimée, Nancy Julien, Hermine Lore Nguena Nguefack, M. Gabrielle Pagé, Line Guénette, Lucie Blais, Sylvie Beaudoin, Christian Bertrand, and Anaïs Lacasse. 2024. “Changing Society, Changing Research: Integrating Gender to Better Understand Physical and Psychological Treatments Use in Chronic Pain Management.” Pain 165 (3): 674–84. https://doi.org/10.1097/j.pain.0000000000003072.
Guertin, Jason Robert, Naomi Hope Chouinard, Amélie Forget, and Lucie Blais. 2024. “Adjusting Historical Costs for Inflation with the Use of Standardized Automated Tools.” ClinicoEconomics and Outcomes Research : CEOR 16:675–78. https://doi.org/10.2147/CEOR.S476426.
Zerriouh, Meriem, Gwenaelle De Clifford-Faugère, Hermine Lore Nguena Nguefack, M. Gabrielle Pagé, Line Guénette, Lucie Blais, and Anaïs Lacasse. 2024. “Pain Relief and Associated Factors: A Cross-Sectional Observational Web-Based Study in a Quebec Cohort of Persons Living with Chronic Pain.” Frontiers in Pain Research (Lausanne, Switzerland) 5:1306479. https://doi.org/10.3389/fpain.2024.1306479.
Audet, Claudie, Meriem Zerriouh, Hermine Lore Nguena Nguefack, Nancy Julien, M. Gabrielle Pagé, Line Guénette, Lucie Blais, and Anaïs Lacasse. 2024. “Where We Live Matters: A Comparison of Chronic Pain Treatment between Remote and Non-Remote Regions of Quebec, Canada.” Frontiers in Pain Research (Lausanne, Switzerland) 5:1291101. https://doi.org/10.3389/fpain.2024.1291101.
De Clifford-Faugère, Gwenaëlle, Hermine Lore Nguena Nguefack, Manon Choinière, M. Gabrielle Pagé, Lucie Blais, Line Guénette, Marc Dorais, and Anaïs Lacasse. 2023. “Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Québec, Canada: An Interrupted Time Series Analysis.” International Journal of Environmental Research and Public Health 20 (15). https://doi.org/10.3390/ijerph20156493.
Guénette, Line, Véronique Turcotte, Laurianne Bélanger, Lucie Blais, Caroline Sirois, Carlotta Lunghi, and Polly Duncan. 2023. “Multimorbidity Treatment Burden Questionnaire (MTBQ): Translation, Cultural Adaptation, and Validation in French-Canadian.” Canadian Journal on Aging = La Revue Canadienne Du Vieillissement 42 (1): 126–34. https://doi.org/10.1017/S0714980822000058.
Zahlan, Ghita, Gwenaelle De Clifford-Faugère, Hermine Lore Nguena Nguefack, Line Guénette, M. Gabrielle Pagé, Lucie Blais, and Anaïs Lacasse. 2023. “Polypharmacy and Excessive Polypharmacy Among Persons Living with Chronic Pain: A Cross-Sectional Study on the Prevalence and Associated Factors.” Journal of Pain Research 16:3085–3100. https://doi.org/10.2147/JPR.S411451.
Yousif, Alia, Catherine Lemière, Amélie Forget, Marie-France Beauchesne, and Lucie Blais. 2022. “Feasibility of Implementing a Web-Based Tool Built from Pharmacy Claims Data (e-MEDRESP) to Monitor Adherence to Respiratory Medications in Primary Care.” Current Medical Research and Opinion 38 (12): 2055–67. https://doi.org/10.1080/03007995.2022.2135835.
Bahamyirou, Asma, Mireille E. Schnitzer, Edward H. Kennedy, Lucie Blais, and Yi Yang. 2022. “Doubly Robust Adaptive LASSO for Effect Modifier Discovery.” The International Journal of Biostatistics 18 (2): 307–27. https://doi.org/10.1515/ijb-2020-0073.
Turcotte, Claudie, Rébecca Fénélon-Dimanche, Catherine Lemière, Marie-France Beauchesne, Bachir Abou-Atmé, Isabelle Chabot, and Lucie Blais. 2022. “Development of a Community Pharmacy-Based Intervention for Patients with Uncontrolled Asthma.” Exploratory Research in Clinical and Social Pharmacy 7 (September):100167. https://doi.org/10.1016/j.rcsop.2022.100167.
